Haris Manzoor KHAN, Samia KİRMANİ, Parvez Anwar KHAN, Urfi İSLAM

Prevalence of chloroquine resistant Plasmodium falciparum malaria in pregnant females attending North Indian hospital

Chloroquine resistance was first reported in South-east Asia and South America region and has now spread to the vast majority of malaria endemic countries. P. falciparum malaria is a cause of high morbidity and mortality in general population as well as in antenatal females. 1. To evaluate the accuracy of different diagnostic tests for diagnosis of malaria in pregnancy. 2. To determine the level of chloroquine resistance in P. falciparum isolates from pregnant females. The study was conducted in Department of Microbiology and Obstetrics and Gynaecology of Jawaharlal Nehru Medical College and Hospital. A total of 156 pregnant females were included in the study. Diagnosis of malaria was done by blood smear examination or antigen detection assay or by Quantitative Buffey Coat assay. P. faciparum was cultured in RPMI 1640 medium and in-vitro drug sensitivity was done by microtest-II WHO sensitivity plates against chloroquine. P. falciparum culture was positive in 66 pregnant females. 28 isolates were found to be resistant to chloroquine. The effective concentration of chloroquine EC 50 was found to be 6.6, EC90 34.3, EC95 45.4, EC99 52.1 nmol/l. High level of chloroquine resistance in pregnant females can lead to serious complications in antenatal patients and their fetuses.

___

1. Ridley RG. Medical need, scientific opportunity and the drive for antimalarial drugs. Nature 2002; 415: 686-693.

2. Foley M, Tilley L. Quinoline antimalarials: mechanisms of action and resistance. International Journal for Parasitology 1997; 27: 231-240.

3. Krogstad DJ, Gluzman IY, Kyle DE, et al. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 1987; 238: 1283-1285.

4. Bruce-Chwatt LJ. Malaria in African infants and children in southern Nigeria. Annals of tropical medicine and parasitology 1952; 46: 173-200.

5. Mvondo JL, James MA, Cambell CC. Malaria and pregnancy in Cameroonian women. Effect of pregnancy on Plasmodium falciparum parasitaemia and the response to chloroquine. Tropical medicine parasitology 1992; 43: 1-5.

6. Galbraith RM, Faulk WP, Galbraith GM, Holbrook TW, Bray RS. The human maternofetal relationship in malaria. Trans R Soc Trop Med Hyg 1980; 74: 52-61.

7. Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983; 61: 1005-1016.

8. White NJ, McGready RM, Nosten FH. New medicines for tropical diseases in pregnancy catch-22. PLoS Med 2008; 5: 133.

9. Ward SA, Sevene EJ, Hastings IM, Nosten F, McGready R. Antimalarial drugs and pregnancy: safety, pharmacokinetics and pharmacovigilance. Lancet Infect Dis 2007; 7: 136-144.

10. Yamada M, Steketee R, Abramowsky C, et al. Plasmodium falciparum associated placental pathology: a light and electron microscopic and immunohistologic study. Am J Trop Med Hyg 1989; 41: 161-168.

11. Plorde JJ, White NJ. Malaria. In: Wilson JD, Braunwald E, Isselbacker KJ et al. (eds). Harrison's Principles of Internal Medicine (12th ed). New York: MacGraw Hill Inc, 1991, pp 782-788.

12. Wyler DJ. Plasmodium species (malaria). In: Mandell GL, Douglas RG, Bennett JE (eds). Principles and Practice of Infectious Diseases (3rd ed). New York: Churchill Livingstone, 1990: 2056-2065.

13. Trager W and Jensen JB. Human malaria parasites in continuous culture. Science 1976; 193: 673-675.

14. World Health Organization. In Vitro Microtest (MARK II) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, sulfadoxine/ pyrimentamine and amodiaquine. World Health Organization 2001, Geneva, Switzerland.

15. Desai M, ter Kuile FO, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007; 7: 93-104.

16. Anvikar AR, Sharma B, Sharma SK, et al. In vitro assessment of drug resistance in Plasmodium falciparum in five States of India. Indian J Med Res 2012; 135: 494-499.

17. Rukaria-Kaumbutho RM, Ojwang SBO, Oyieke JB. Resistance to chloroquine therapy in pregnant women with malaria parasitemia. International Journal of Gynecology and Obstetrics 1996; 53: 235-41.

18. Shujatullah F, Khan HM, Khatoon A, Khan PA, Ashfaq M. In vitro chloroquine resistance in Plasmodium falciparum isolates from tertiary care hospital. Malaria Research and Treatment 2012; 4 pages. doi:10.1155/2012/538481.

19. Kwiatkowski D, Bate C. Inhibition of tumor necrosis factor (TNF) by antimalarial drugs used in cerebral malaria. Trans R Soc Trop Med Hyg 1995; 52: 159-161.

20. Bouyou-Akotet MK, Ionete-Collard DE, Mabika-Manfoumbi M, et al. Prevalence of Plasmodium falciparum infection in pregnant women in Gabon. Malaria Journal 2003; 2: 18.